Does Vyvanse (lisdexamfetamine) affect fertility?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 7, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Vyvanse (Lisdexamfetamine) Effects on Fertility

There is currently limited direct evidence regarding the effects of lisdexamfetamine (Vyvanse) on fertility, but as a prodrug that converts to dextroamphetamine, it is not specifically associated with fertility impairment based on available guidelines and research.

Mechanism of Action and Conversion

Lisdexamfetamine is a prodrug that is enzymatically hydrolyzed primarily in the blood to its active form, d-amphetamine 1. This conversion occurs through a process that is:

  • Independent of gastrointestinal pH and transit times
  • Primarily occurring in the bloodstream
  • Resulting in the active d-amphetamine component that affects neurotransmitter systems

As a CNS stimulant, d-amphetamine works by:

  • Inhibiting dopamine transporter (DAT) and noradrenaline transporter (NAT)
  • Increasing dopamine and noradrenaline concentrations in the synaptic cleft
  • Promoting the release of these neurotransmitters 1

Fertility Considerations

Male Fertility

While there is no direct evidence specifically for lisdexamfetamine's effects on male fertility, related research on methylphenidate (another ADHD stimulant medication) suggests:

  • No negative impact on sperm parameters in adults with ADHD
  • Some studies even showed increased sperm concentration, total sperm count, and total sperm motility among methylphenidate users compared to non-users 2

Female Fertility

The 2024 American Journal of Obstetrics and Gynecology guidelines note:

  • Limited published information specifically on lisdexamfetamine use in pregnancy
  • As lisdexamfetamine converts to dextroamphetamine, information about amphetamines is generally applicable
  • Amphetamines do not appear to be associated with major congenital malformations or significant adverse obstetrical outcomes 3

Clinical Considerations

Safety Profile

The FDA label for lisdexamfetamine does not specifically mention fertility concerns but does advise:

  • Breastfeeding is not recommended during treatment due to potential serious adverse reactions in nursing infants
  • These reactions include cardiovascular effects, blood pressure and heart rate increases, growth suppression, and peripheral vasculopathy 4

Common Side Effects

The most common side effects of lisdexamfetamine that could indirectly affect sexual function or fertility planning include:

  • Decreased appetite
  • Insomnia
  • Irritability
  • Affect lability 4, 5

Important Caveats

  1. Limited Direct Research: There are no comprehensive studies specifically examining lisdexamfetamine's direct effects on fertility parameters in humans.

  2. Individual Variation: Response to medication can vary significantly between individuals.

  3. Underlying Condition Considerations: Untreated ADHD may itself impact relationship functioning and family planning decisions.

  4. Medication Alternatives: For patients specifically concerned about fertility, other ADHD treatment options could be considered based on individual needs and response.

Monitoring Recommendations

For patients taking lisdexamfetamine who are concerned about fertility:

  • Regular follow-up appointments to assess medication efficacy and side effects
  • Discussion of family planning goals with healthcare providers
  • Consideration of alternative treatments if fertility concerns persist
  • Appropriate referral to reproductive specialists if conception difficulties occur

In conclusion, while direct evidence is limited, current guidelines and research do not indicate that lisdexamfetamine (Vyvanse) has significant negative impacts on fertility in either men or women when used as prescribed for ADHD treatment.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.